Blood pressure-independent effects of calcium antagonists
Author:
Godfraind Théophile
Publisher
Birkhäuser Basel
Reference68 articles.
1. Berkels R, Egink G, Marsen TA, Bartels H, Roesen R and Klaus W. Nifedipine increases endothe- lial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 37: 240–245, 2001
2. Block LH, Emmons LR, Vogt E, Sachinidis A, Vetter W and Hoppe J. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA 86: 2388–2392, 1989
3. Block LH, Matthys H, Emmons LR, Perruchoud A, Erne P and Roth M. Ca2+-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA 88: 9041–9045, 1991
4. Brasier AR and Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465–475, 1996
5. Brovkovych VV, Kalinowski L, Muller-Peddinghaus R and Malinski T. Synergistic antihypertensive effects of nifedipine on endothelium: concurrent release of NO and scavenging of superoxide. Hypertension 37: 34–39, 2001